Luo Ying has filed 3 insider transactions across 1 company since August 2024.
Most recent transaction: a sale of 179 shares of GYRE THERAPEUTICS, INC. ($GYRE) on May 05, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Luo Ying | Chief Executive Officer | S | Common Stock | 179 | $8.01 | 2,575,362.0000 | 103,971,546 | 0.01% | 0.00% |
| May 6, 2026 | GYRE THERAPEUTICS, INC. | $GYRE | Luo Ying | Chief Executive Officer | S | Common Stock | 10136 | $8.04 | 2,565,226.0000 | 103,971,546 | 0.39% | 0.01% |
| Aug. 14, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Luo Ying | Not found | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 65,831,675 | 9999.99% | 0.04% |